Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the Board

25-Aug-2009 - USA

Amylin Pharmaceuticals, Inc. announced that its Board of Directors has elected Paulo F. Costa as Chairman of the Board, effective immediately.

Mr. Costa was formerly President and Chief Executive Officer of Novartis U.S. Corporation, where he held several other executive positions, including Head of the Americas and President and Chief Executive Officer of Novartis Pharmaceutical Corporation. Prior to joining Novartis, Mr. Costa worked at Johnson & Johnson for 30 years, where he served as President of Janssen Pharmaceutica, Executive Vice President, Global Franchise Development, and was a member of Johnson & Johnson's Group Operating Committee. Mr. Costa has held various sales and marketing positions and has more than 20 years of general management experience, having launched 10 pharmaceutical products in various therapeutic areas in the U.S. market. He was elected to Amylin's Board at the Company's Annual Meeting of Stockholders on May 27, 2009.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances